Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients

Journal of Medical Virology

Volumn 79, Issue 11, 2007, Pages 1679-1685

  Filippini, Pietro ^a   Coppola, Nicola ^a   Pisapia, Raffaella ^a   Martini, Salvatore ^a   Marrocco, Cecilia ^a   Di Martino, Filomena ^a   Sagnelli, Caterina ^a   Filippini, Alberico ^a   Sagnelli, Evangelista ^a,b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Azienda Ospedaliera San Sebastiano   (Italy)

Author keywords

Antiretroviral treatment; HBV HCV coinfection; HBV HIV coinfection; HCV HIV coinfection; Occult HBV infection

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SUPERINFECTION; VIRUS REPLICATION;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; ANTIBODIES, VIRAL; DNA, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL; VIRAL LOAD; VIRUS REPLICATION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 34748815162     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20992     Document Type: Article

References (31)

1. Anderson KB, Guest JL, Rimland D. 2004. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: Data from the HIV Atlanta VA Cohort Study. Clin Infect Dis 39:1507-1513.
2. Arribas JR, González-Garcia J, Lorenzoa A, Monterob D, Ladron de Guevarab C, Montesa M, Hernandeza S, Pachecoa R, Penaa JM, Vazqueza JJ. 2005. Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in Madrid, Spain. AIDS 19:1361-1365.
3. Benhamou Y. 2004. Antiretroviral therapy and HIV/hepatitis B virus coinfection. Clin Infect Dis 38:S98-S103.
4. Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA. 2000. Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA Panel. JAMA 28:381-390.
5. CDC. 1993. revises HIV classification system, AIDS definition. W V Med J 89:74.
6. Coppola N, Marrocco C, Di Caprio D, Coviello G, Scolastico C, Filippini P, Sagnelli E. 2003. Acute hepatitis B and C virus coinfection: A virological and clinical study of 3 cases. Clin Infect Dis 36:528-532.
7. Cribier B, Rey D, Schmitt C, Lang GM, Kim A, Stoll-Keller F. 1995. High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS 9:1131-1136.
8. Eyster ME, Sanders JC, Battegay M, Di Bisceglie AM. 1995. Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV-infected hemophiliacs with chronic hepatitis B and C. Dig Dis Sci 40:1583-1588. 10.
9. Filippini P, Coppola N, Pisapia R, Scolastico C, Marrocco C, Zaccariello A, Nacca C, Sagnelli C, De Stefano G, Ferraro T, De Stefano C, Sagnelli E. 2006. Impact of occult HBV infection in HIV patients naive for antiretroviral therapy. AIDS 20:1253-1260.
10. Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, et al. 2000. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 356:1800-1805.
11. Ishak K, Baptista A, Binachi L, Callea F, De Groote J, Gudat F. 1995. Histological grading and staging of chronic hepatitis. J Hepatol 22:696-699.
12. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kierman TW, Wollman J. 1981. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic hepatitis. Hepatology 1:431-435.
13. Law WP, Duncombe CJ, Mahanontharit A, Boyd MA, Ruxrungtham K, Lange JM. et al. 2004. Impact of viral hepatitis coinfection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort. AIDS 18:1169-1177.
14. Liaw YF. 1995. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 22:1101-1108.
15. Mathurin P, Thibault V, Kadidja K, Ganne-Carrie N, Moussalli J, Younsi ME, Di Martino V, Lunel F, Charlotte F, Vidaud M, Opolon P, Poynard T. 2000. Replication status and histological features of patients with triple (B,C,D) and dual (B,C) hepatic infections. J Viral Hep 7:15-22.
16. Ockenga J, Tillmann HL, Trautwein C. 1997. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J Hepatol 27:18-24.
17. Puoti M, Torti C, Bruno R, Filice G, Carosi G. 2006. Natural history of chronic B in co-infected patients. J Hepatol 44:S65-S70.
18. Raimondo G, Brunetto MR, Pontisso P, Smedile A, Maina AM, Saitta C, Squadrito G, Tono N. 2006. and the Associazione Italiana Studio Fegato (AISF) Cooperative Group. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients. Hepatology 1:99-106.
19. Raimondo G, Pollicino T, Cacciola I, Squadrito G. 2007. Occult hepatitis B virus infection. J Hepatol 46:160-170.
20. Sagnelli E, Coppola N, Scolastico C, Filippini P, Santantonio T, Stroffolini T, Piccinino F. 2000. Virological and clinical expressions of reciprocal inhibitory effect of hepatitis B, C and Delta viruses in patients with chronic hepatitis. Hepatology 32:1106-1110.
21. Sagnelli E, Coppola N, Messina V, Di Caprio D, Marrocco C, Marotta A, Onofrio M, Scolastico C, Filippini P. 2002. HBV superinfection in HCV chronic carriers, viral interaction and clinical course. Hepatology 36:1285-1291.
22. Sagnelli E, Pasquale G, Coppola N, Scarano F, Marrocco C, Scolastico C, Santantonio T, Gentile A, Piccinino F. 2004. Influence of chronic HBV-HCV concurrent infection on liver histology. Infection 32:144-148.
23. Sagnelli E, Coppola N, Marrocco C, Onofrio M, Sagnelli C, Coviello G, Scolastico C, Filippini P. 2006. Hepatitis C virus superinfection in hepatitis B virus chronic carriers: A reciprocal viral interaction and a variable clinical course. J Clin Virol 35:317-320.
24. Sheen IS, Liaw YF, Lin DY, Chu CM. 1994. Role of hepatitis C and Delta viruses in the termination of chronic hepatitis B surface antigen carrier state: A multivariate analysis in a longitudinal follow-up study. J Infect Dis 170:358-361.
25. Sherman KE, Rouster SD, Chung RT, Rajicic N. 2002. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis 34:831-837.
26. Sterling RK. 2003. Triple infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus: A clinical challenge. Am J Gastroenterol 10:2130-2134.
27. Sulkowski MS, Thomas DL. 2003. Hepatitis C in the HIV-infected person. Ann Intern Med 138:197-207.
28. Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. 2002. Hepatitis C and progression of HIV disease. J Am Med Assoc 288:199-206.
29. Thio C, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Munoz A., 2002. et al. HIV-1, hepatitis B virus and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360:1921-1926.
30. Yeni PG, Hammer SM, Hirsch MS, Saag MS, Schechter M, Carpenter CC, Fischl MA, Gatell JM, Gazzard BG, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Schooley RT, Thompson MA, Vella S, Volberding PA. 2004. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA 292:251-265.
31. Zarski JP, Bohn B, Bastie A, Pawlotsky JM, Baud M, Bost-Bezeaux F, van Nhieu JT, Seigneurin JM, Buffet C, Dhumeaux D. 1998. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 28:27-33.